Menu Search
Equities

Feedback PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GZM0:FRA

Feedback PLC

Actions
  • Price (EUR)0.119
  • Today's Change0.001 / 0.85%
  • Shares traded--
  • 1 Year change-44.39%
  • Beta0.4778
Data delayed at least 15 minutes, as of Feb 12 2026 07:04 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. The Company’s segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is its communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multidisciplinary team working and diagnostic-enhanced advice and guidance. CareLocker is its patient-facing platform that gives patients access and control over their diagnostic and other clinical data.

  • Revenue in GBP (TTM)885.62k
  • Net income in GBP-7.32m
  • Incorporated1958
  • Employees28.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.